Blood test could predict bleeding risk in cancer patients
NCT ID NCT07653672
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to create a score that uses a special blood test to predict bleeding risk in people with blood cancers and very low platelet counts. Researchers will take an extra blood sample from 410 participants and analyze it with viscoelastometric tests. The goal is to identify who is truly at risk of bleeding, so platelet transfusions can be given only when needed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple blood test that helps doctors predict which patients are at risk of bleeding, allowing more targeted use of platelet transfusions.
- What could go wrong
- This is an early exploratory study with only 410 participants at one hospital. The score may not work as well in other settings or patients, and it does not test any new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE MARROW FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can specially trained immune cells flush out hidden HIV?
- Frailty check may steer safer cancer care for seniors
- Could gratitude exercises aid blood cancer recovery?
- AI platform aims to unlock Real-World cancer data on a massive scale
- Can a new tracer light up cancer growth?
- Could a platelet-boosting drug shorten recovery after stem cell transplants?